A researcher with ambitious goals.

Currently working on patient-derived conditionally reprogrammed cells (CRCs) to optimize personalized medicine approaches, as well as identifying biomarkers for the response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.